NCT04833842 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Artieta-Pinedo I, Paz-Pascual C, Grandes G, Remiro-Fernandezdegamboa G, Odriozola-Hermosilla I, Bacigalupe A, Payo J
The benefits of antenatal education for the childbirth process in Spain. Nurs Res. 2010 May-Jun;59(3):194-202. doi: 10.1097/NNR.0b013e3181dbbb4e.
Byrne J, Hauck Y, Fisher C, Bayes S, Schutze R
Effectiveness of a Mindfulness-Based Childbirth Education pilot study on maternal self-efficacy and fear of childbirth. J Midwifery Womens Health. 2014 Mar-Apr;59(2):192-7. doi: 10.1111/jmwh.12075. Epub 2013 Dec 10.
Munkhondya BMJ, Munkhondya TE, Chirwa E, Wang H
Efficacy of companion-integrated childbirth preparation for childbirth fear, self-efficacy, and maternal support in primigravid women in Malawi. BMC Pregnancy Childbirth. 2020 Jan 21;20(1):48. doi: 10.1186/s12884-019-2717-5.
Toohill J, Fenwick J, Gamble J, Creedy DK, Buist A, Turkstra E, Ryding EL
A randomized controlled trial of a psycho-education intervention by midwives in reducing childbirth fear in pregnant women. Birth. 2014 Dec;41(4):384-94. doi: 10.1111/birt.12136. Epub 2014 Oct 9.

The Effect of Pre-Birth Program Developed Based on Health Belief Model on Fear of Birth, Birth Self-Efficacy, Birth Process and Perception in Primigravida Pregnant Women

Details for clinical trial NCT04833842

Clinical trial NCT04833842 - References